| BALIAKAS, P., M. MATTSSON, A. HADZIDIMITRIOU, E. MINGA, A. AGATHANGELIDIS, LA. SUTTON, L. SCARFO, Z. DAVIS, XJ. YAN, Karla PLEVOVÁ, Y. SANDBERG, F. JUHL VOJDEMAN, T. TZENOU, CC. CHU, S. VERONEZE, L. MANSOURI, KE. SMEDBY, V. GIUDICELLI, F. NGUYEN KHAC, P. PANAGIOTIDIS, G. JULIUSSON, A. ANAGNOSTOPOULOS, MP. LEFRANC, L. TRENTIN, M. CATHERWOOD, M. MONTILLO, CU. NIEMANN, AW. LANGERAK, Šárka POSPÍŠILOVÁ, N. STAVROYIANNI, N. CHIORAZZI, D. OSCIER, D. JELINEK, T. SHANAFELT, Nikos DARZENTAS, C. BELESSI, F. DAVI, P. GHIA, R. ROSENQUIST a K. STAMATOPOULOS. No improvement in long-term overal survival after the introduction of chemo(immuno)therapy for chronic lymphocytic leukemia patients belonging to stereotyped subsets 2. In Haematologica (2016); 101(s1): 231 (21st Congress of the EHA). 2016. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1363940,
author = {Baliakas, P. and Mattsson, M. and Hadzidimitriou, A. and Minga, E. and Agathangelidis, A. and Sutton, LA. and Scarfo, L. and Davis, Z. and Yan, XJ. and Plevová, Karla and Sandberg, Y. and Juhl Vojdeman, F. and Tzenou, T. and Chu, CC. and Veroneze, S. and Mansouri, L. and Smedby, KE. and Giudicelli, V. and Nguyen Khac, F. and Panagiotidis, P. and Juliusson, G. and Anagnostopoulos, A. and Lefranc, MP. and Trentin, L. and Catherwood, M. and Montillo, M. and Niemann, CU. and Langerak, AW. and Pospíšilová, Šárka and Stavroyianni, N. and Chiorazzi, N. and Oscier, D. and Jelinek, D. and Shanafelt, T. and Darzentas, Nikos and Belessi, C. and Davi, F. and Ghia, P. and Rosenquist, R. and Stamatopoulos, K.},
booktitle = {Haematologica (2016); 101(s1): 231 (21st Congress of the EHA)},
title = {No improvement in long-term overal survival after the introduction of chemo(immuno)therapy for chronic lymphocytic leukemia patients belonging to stereotyped subsets 2.},
year = {2016}
}
TY - CONF
ID - 1363940
AU - Baliakas, P. - Mattsson, M. - Hadzidimitriou, A. - Minga, E. - Agathangelidis, A. - Sutton, LA. - Scarfo, L. - Davis, Z. - Yan, XJ. - Plevová, Karla - Sandberg, Y. - Juhl Vojdeman, F. - Tzenou, T. - Chu, CC. - Veroneze, S. - Mansouri, L. - Smedby, KE. - Giudicelli, V. - Nguyen Khac, F. - Panagiotidis, P. - Juliusson, G. - Anagnostopoulos, A. - Lefranc, MP. - Trentin, L. - Catherwood, M. - Montillo, M. - Niemann, CU. - Langerak, AW. - Pospíšilová, Šárka - Stavroyianni, N. - Chiorazzi, N. - Oscier, D. - Jelinek, D. - Shanafelt, T. - Darzentas, Nikos - Belessi, C. - Davi, F. - Ghia, P. - Rosenquist, R. - Stamatopoulos, K.
PY - 2016
TI - No improvement in long-term overal survival after the introduction of chemo(immuno)therapy for chronic lymphocytic leukemia patients belonging to stereotyped subsets 2.
ER -
BALIAKAS, P., M. MATTSSON, A. HADZIDIMITRIOU, E. MINGA, A. AGATHANGELIDIS, LA. SUTTON, L. SCARFO, Z. DAVIS, XJ. YAN, Karla PLEVOVÁ, Y. SANDBERG, F. JUHL VOJDEMAN, T. TZENOU, CC. CHU, S. VERONEZE, L. MANSOURI, KE. SMEDBY, V. GIUDICELLI, F. NGUYEN KHAC, P. PANAGIOTIDIS, G. JULIUSSON, A. ANAGNOSTOPOULOS, MP. LEFRANC, L. TRENTIN, M. CATHERWOOD, M. MONTILLO, CU. NIEMANN, AW. LANGERAK, Šárka POSPÍŠILOVÁ, N. STAVROYIANNI, N. CHIORAZZI, D. OSCIER, D. JELINEK, T. SHANAFELT, Nikos DARZENTAS, C. BELESSI, F. DAVI, P. GHIA, R. ROSENQUIST a K. STAMATOPOULOS. No improvement in long-term overal survival after the introduction of chemo(immuno)therapy for chronic lymphocytic leukemia patients belonging to stereotyped subsets 2. In \textit{Haematologica (2016); 101(s1): 231 (21st Congress of the EHA)}. 2016.
|
